: Drug Discovery Summit

Drug Discovery Summit

09 - 10 June 2022 | Berlin, Germany
+ Digital Day: 13 June 2022 | Online
22nd Annual
Drug Discovery Summit
26 - 27 October 2021 | London, UK
+ Digital Day: 28 October 2021 | Online

An invaluable resource for those looking to improve efficiency, increase pipelines and keep up to date with the latest advances. Featuring key insights into protein degradation, AI/ML in drug discovery, and much more

The Drug Discovery Summit features...

Over 400 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

A look at the future of drug discovery in new modalities such as protein degradation, RNA based therapeutics and case studies on the identification and Validation of Novel Targets

The latest updates on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling, and novel RNA drug targets

Insights into drug discovery strategies & next generation therapeutics, empowering drug discovery with chemical biology, target validation, drug profiling and protein degradation technologies

An evaluation of the Development of Clinical Biomarker translation and patient engagement

Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features

Agenda at a Glance

Day One

Morning Sessions:

Stream 1: Identification and Validating Novel Targets – Case Study Presentations
Stream 2: Phenotypic Based Discovery & Screening Approaches
Stream 3: New Modalities And Challenging Targets: Targeted Protein Degradation and PROTAC

Afternoon Interactive Sessions:

Roundtable Discussions:
– Identification and Validating Novel Targets
– New Modalities And Challenging Targets: Targeted Protein Degradation & PROTAC

Workshops:
– Molecular Glue for New Drug Development Workshop
– E3 Ubiquitin Ligases and Targeted Protein Degradation
– Overview Of Available Methods To Characterize The Compound – Target Interaction On A Molecular Level Via SPR, MST, ITC and TSA

Day Two

Morning Sessions:

Stream 1: New Modalities And Challenging Targets: RNA based Therapeutics
Stream 2: Animal and Disease Modelling, Organoid based Discovery, 3D Media

Afternoon Interactive Sessions:

Roundtable Discussions:
– Target Discovery and Animal Modelling
– Translational Biomarkers and Patient Engagement

Workshop: Development And Identification Of Biomarkers, New Targets And Combination Therapies For Cancer

Key Speakers

The 2021 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Malcolm Weir

Malcolm Weir

Executive Officer, Vice President
Sosei Heptares
Ulrich Betz

Ulrich Betz

Vice President Innovation, Head of Department Innovation Incubator
Merck
Matthias Frech

Matthias Frech

Director, Molecular Interactions & Biophysics
Merck
Clara Christ

Clara Christ

Head of Computational Molecular Design
Bayer
Olivier Nosjean

Olivier Nosjean

Head of Open Innovation and Scientific Affairs, R&D
Servier
Nadeem Sarwar

Nadeem Sarwar

Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies
Eisai

Copyright Oxford Global Marketing Limited. All rights reserved.